Clincosm LogoSign in Get a demo

Diffuse Large B Cell Lymphoma

Showing NaN - NaN of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma Trial in Hangzhou (Rituximab, Lenalidomide, Zanubrutinib and RCHOP)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Rituximab, Lenalidomide, Zanubrutinib and RCHOP
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Mar 21, 2022

Hodgkin Lymphoma, NK/T Cell Lymphoma, Peripheral T Cell Lymphoma, Unspecified Trial in Hangzhou (Anti CD30 CAR-T Cell Injection)

Not yet recruiting
  • Hodgkin Lymphoma
  • +7 more
  • Anti CD30 CAR-T Cell Injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of medicine, Zhejiang Uni
Jan 12, 2022

Diffuse Large B Cell Lymphoma Trial in China (ICP-022)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Haerbin, Heilongjiang, China
  • +5 more
Jul 28, 2021

Diffuse Large B Cell Lymphoma Trial in Shanghai, Hangzhou (JWCAR029 (CD19-targeted Chimeric Antigen Receptor Cells))

Recruiting
  • Diffuse Large B Cell Lymphoma
  • JWCAR029 (CD19-targeted Chimeric Antigen Receptor Cells)
  • Shanghai, Shanghai, China
  • +1 more
Mar 22, 2021

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in China (CD19-targeted Chimeric Antigen

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
  • Beijing, Beijing, China
  • +9 more
Jan 17, 2021

Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in Hangzhou (Sintilimab)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 2, 2020

Diffuse Large B Cell Lymphoma Trial in Hangzhou (Autologous humanized anti-CD19 and anti-CD20 dual specific CAR-T Cells)

Unknown status
  • Diffuse Large B Cell Lymphoma
  • Autologous humanized anti-CD19 and anti-CD20 dual specific CAR-T Cells
  • Hangzhou, Zhejiang, China
    First Affiliated Hospital of Zhejiang University
Aug 25, 2020

Diffuse Large B Cell Lymphoma Trial in Hangzhou (Chidamide + R-CHOP regimen)

Unknown status
  • Diffuse Large B Cell Lymphoma
  • Chidamide + R-CHOP regimen
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of Zhejiang University
Aug 1, 2018